Table 3.
Surgical and pathological outcomes of patients who underwent surgery
| Characteristics | No (%) or median (range) |
| R0 resection | 20 (100%) |
| Surgical approach | |
| MIE | 20 (100%) |
| OE | 0 |
| Pathological response | |
| MPR | 15 (78.9%) |
| PCR | 9 (47.4%) |
| yp T0 | 11 (57.9%) |
| yp N0 | 13 (68.4%) |
| Downstating of T stage | |
| Yes | 16 (84.2%) |
| No | 3 (15.8%) |
| Downstating of N stage | |
| Yes | 16 (84.2%) |
| No | 3 (15.8%) |
| Downstating of TNM stage | |
| Yes | 15 (78.9%) |
| No | 4 (21.1%) |
| No of resected lymph nodes | 26 (14–52) |
| No of positive lymph nodes | 2 (1-6) |
| Surgical complications | |
| Anastomotic leakage | 3 (15.0%) |
| Arrhythmia | 3 (15.0%) |
| Pneumonia | 2 (10.0%) |
| Vocal cord paralysis | 2 (10.0%) |
| Cervical chylous leakage | 1 (5.0%) |
The surgical outcome and complications were evaluated in 20 patients and pathological outcomes were evaluated in 19 patients.
MIE, minimal invasive esophagectomy; MPR, major pathological response; OE, open esophagectomy; PCR, pathological completed response; TNM, tumor, node and metastasis.